Navigation Links
Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
Date:1/18/2011

a key presence in the San Francisco Bay Area biotechnology community through its South San Francisco facility, one of the company's key research centers.

About Amgen Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, psoriasis, psoriatic arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

About Boehringer IngelheimBoehringer Ingelheim is one of the world's leading companies for contract development and manufacturing of biopharmaceuticals. All types of services from mammalian cell line or microbial strain development to final drug production and global market supply can be delivered within a one-stop-shop concept. Boehringer Ingelheim has brought 18 molecules to market and has many years of experience in multiple molecule classes such as monoclonal antibodies, recombinant proteins, interferons, enzymes, fusion molecules, novel scaffold proteins and plasmid DNA. For more information please visit www.biopharma-cmo.com.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. For over 125 years, the family-owned company has been committed to researching, developing, manufacturing and marketing novel pr
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
2. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
3. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
4. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
5. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
6. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
7. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
10. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
11. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)...  Today, the National Patient Advocate Foundation acknowledges that ... Representatives recently approved a bill that would prohibit insurers ... out-of-pocket fees for newer, more expensive oral anti-cancer drugs ... severe side-effects. However, the bill was amended to include ... to be a barrier to patients with cancer and ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... 15, 2007 - Gemin X Biotechnologies,Inc. announced today ... that its lead compound, obatoclax (GX15-070), induced,cell death ... lines and,primary cells from 11 MCL patients. Obatoclax ... all relevant members of,the Bcl-2 protein family, a ...
... Showed Bioequivalence , LONDON, UK and ATLANTA, US, ... Sciele Pharma. Inc. (NASDAQ:SCRX) today,announce the successful completion ... of Sular, a calcium ,channel blocking agent for ... showed that the new Sular formulation is,bioequivalent to ...
Cached Medicine Technology:Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3SkyePharma and Sciele Pharma Announce Successful Completion of New,Sular Formulation Clinical Trial Programme 2SkyePharma and Sciele Pharma Announce Successful Completion of New,Sular Formulation Clinical Trial Programme 3
(Date:5/19/2013)... 19, 2013 Exciting new Skin Brushes ... reintroducing a great practice known through the ages but ... as dry body brushing, has so many benefits for ... Sublime Beauty®. "We love that circulation and lymphatic systems ... organ, the skin, is supported through Skin Brushing." , ...
(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases de Yoga ... by the Sivananda Yoga Vedanta Center. The center ... Norte). Classes are 90 minutes and are offered all ... a calm environment, allowing visitors to enjoy the benefits ... among others. , The Yoga classes follow the following ...
(Date:5/19/2013)... May 19, 2013 Minor fender benders ... road that require parties to the accident to respond ... Disease Control and Prevention (CDC) data from 2010, accidents, ... death (i). In fact, in 2005, automobile ... Additionally, more than 2.3 million drivers and passengers ...
(Date:5/18/2013)... Cambridge House of Maryville , a ... East area, is hosting a Memorial Day Weekend Barbecue from ... The community, which is located at 6960 State Rte. 162 ... those on Medicaid, who need some help to maintain their ... off by homemade ice cream for dessert,” says Tracy Skaer-Henry, ...
(Date:5/18/2013)... 2013 The American Society for Gastrointestinal Endoscopy (ASGE) ... during the ninth annual ASGE Crystal Awards on Sunday, ... Foundation, this year,s event will begin at ... , Held in conjunction with Digestive Disease Week ... leadership, research and scientific pursuit. The event will recognize ...
Breaking Medicine News(10 mins):Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Metro East Affordable Assisted Living Community to Host Memorial Day Weekend Barbecue 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7
... ... Aging Month, an annual observance designed to raise awareness on the positive aspects of ... of the nation,s largest not-for-profit aging services organizations, offer the following simple and effective ... ...
... , Proposed law would regulate teens, right to ... the military , , WASHINGTON, Aug. 18 ... Suffolk teens under the age of 18 from using a sun-bed. ... the following statement regarding the bill: , , It ...
... , , EMERYVILLE, Calif., ... company, announced today that it has closed a $40 million Series ... Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also ... company announced the election of George M. Rehm, Managing Partner of ...
... New data show nanotechnology-related activities in every ... Aug. 18 Every state can now lay claim to the ... by the Project on Emerging Nanotechnologies (PEN) highlights more than 1,200 ... states and in the District of Columbia that are involved in ...
... cardiovascular complications , TUESDAY, Aug. 18 (HealthDay News) ... snoring, interrupted breathing and sleep disruption -- nearly double ... middle-aged and elderly men, according to major new research. ... an increased death risk, as much as 17 percent, ...
... , SCHAUMBURG, Ill., Aug. 18 The ... Motor o la, Inc. (NYSE: MOT ... Vulnerability Assessment solution , a patented wireless security technology aimed at proactively ... new method to secure wi r eless networks ...
Cached Medicine News:Health News:7 Easy Tips for Healthy Aging 2Health News:Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun-Beds 2Health News:Adamas Pharmaceuticals Raises $40 Million in Series D Financing 2Health News:Adamas Pharmaceuticals Raises $40 Million in Series D Financing 3Health News:Putting Nanotechnology on the Map 2Health News:Putting Nanotechnology on the Map 3Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 2Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 3Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 2Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 3Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 5
... Wavefront analysis with the WASCA Analyzer ... diagnosis. Unlike existing diagnostic techniques, the WASCA ... eye from thecornea to the retina. ... Analyzer also supplies higher order aberrations which ...
... is a flexible, total solution. , ,Kojair Tech ... since 1983. A major part of our production ... from all the different areas of clean-air needs ... Tech Oy is a comprehensive supplier. We are ...
The Universal Knee Positioner(s)™ reduces surgeon fatigue while assisting in the stabilization of a patient's leg during surgury....
The De mayo Hip Positioner is simple, adjustable, has lateral decubitus positioning, and can be set up with six simple steps....
Medicine Products: